Pfizer Inc. (PFE)
27.28
+0.32
(+1.19%)
USD |
NYSE |
Mar 25, 16:00
27.25
-0.03
(-0.11%)
Pre-Market: 07:04
Pfizer Cash from Investing (Quarterly) : -6.146B for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -693.00M |
| Gilead Sciences, Inc. | -1.835B |
| Johnson & Johnson | -4.485B |
| Regeneron Pharmaceuticals, Inc. | 220.30M |
| Moderna, Inc. | -48.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.349B |
| Cash from Financing (Quarterly) | 596.00M |
| Free Cash Flow | 9.076B |
| Free Cash Flow Per Share (Quarterly) | 0.7921 |
| Free Cash Flow to Equity (Quarterly) | -1.20B |
| Free Cash Flow to Firm (Quarterly) | 5.214B |
| Free Cash Flow Yield | 5.83% |